My favourite PTM is Ubiquitinylation

Thank you for ranking Ubiquitinylation as your favourite PTM to be integrated in our platform.

 

 Do you have questions about this assay and how it can support your research projects ?

Are you interested to participate in the final development stages ?

 

 Contact us  anytime for further information or to discuss your project - This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 Newsletter:   Register for our newsletter to receive updates on the results of this survey and the availability of our novel PTM analysis services.

 

 Already available: scioPhospho for protein + phosphorylation profiling

 Would you like to learn more about our scioPhospho assay to analyse protein levels and phosphorylation status in parallel ?

 

 

 

scioPhospho: parallel protein and phosphorylation profiling
scioPhospho: Eight treated cell line samples were compared with 8 control samples. Several proteins were identified as differentially expressed (x-axis) and/or phosphorylated (y-axis). While the left plot provides an overview on expression / phosphorylation differences for all tested proteins in the two sample groups, individual levels are depicted in the plots on the right. The sample status is indicated as C = control or T = treated.

Our service portfolio

scioPhospho: protein profiling and phosphorylation status

scioPhospho: protein profiling and phosphorylation status

scioPhospho combines the advantages of a robust and cost-efficient protein expression profiling using scioDiscover with information on phosphorylation status. This combination provides a comprehensive overview on signalling events and pathway activity regulation. Features 900 highly relevant proteins are profiled in a single assay Phosphorylation status combined with protein expression levels…
Read more
scioDiscover - Protein Profiling on expression level

scioDiscover - Protein Profiling on expression level

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised…
scioSpot - Microarray Production

scioSpot - Microarray Production

Microarrays - tailor-made for you. With more than 10 years of experience, Sciomics is the ideal partner for designing and printing your antibody-, protein-, peptide- or DNA/RNA chips. Benefit from…
scioCD - Cell surface marker and Cytokine profiling

scioCD - Cell surface marker and Cytokine profiling

Characterise a certain cell type ? Cell composition in a certain tissue sample ? In-depth profiling of CD-marker expression ? Increase your throughput at high sensitivity levels ? You aim…

News

New article | Role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing

| February 2018 | Researchers at Rostock University Medical Center published an article on the role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing in the International Journal of Molecular Sciences.

> Customer Testimonial Bhavani Kowtharapu:

"I am really happy with service of Sciomics. Very friendly team and really fast service and we have the results in our hand including bioinformatics analysis within 2 weeks. Thank you Sciomics team."

> More testimonials

Meeting | Sciomics @ BIO-Europe Spring

| March 12-14 2018 | Meet Dr. Christoph Schröder at BIO-Europe Spring in Amsterdam to learn about the benefit of pathway activity profilings in pre-clinical research. Our scioPhospho service combines the analysis of protein levels of more than 1,000 proteins with the knowledge on the phosphorylation status and thereby enables profound insights in the activity of the major biomedical pathways.

Meeting | Sciomics @ Int. Conference on Perspectives in Precision Medicine

| February 28 - March 1 2018 | Meet Dr. Ronny Schmidt at the International Conference on Perspectives in Precision Medicine in Copenhagen to learn how Sciomics can support you in the identification and verification of protein biomarkers for precision medicine.

Research | Participation in collaborative clinical studies for the treatment of MCDS

| January 2018 | The multinational consortium MCDS-therapy has been granted 5.7 Million Euro by the European Commission for the development of novel therapeutic approaches in rare skeletal disorders. Sciomics' expertise with the antibody microarray technology herein serves as a valuable tool for biomarker identification and personalized treatment monitoring. > Press release

New article | Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells

| January 2018 | A scioDiscover protein microarray study contributed to an article in Cell Reports. In this study Gerard Ruiz-Babot et al. analysed a donor specific reprogramming of cells.

Customer testimonial Leonardo Guasti, PhD (senior author):

This has undoubtedly opened new avenues in our research. We have found the Sciomics team to be extremely helpful and efficient during the whole process, from advising the best strategy to the final interpretation of results.

> More testimonials

A glas full of hope | Ein Glas Hoffnung

| January 2018 | Article on the StartUp Sciomics and our antibody microarray platform by our partner SCHOTT nexterion.

> English version "A glass full of hope"

> Deutsche Version "Ein Glas Hoffnung"

Tweets